Malignant neoplasm of ileum
ICD-10 C17.2 is a billable code used to indicate a diagnosis of malignant neoplasm of ileum.
Malignant neoplasm of the ileum refers to cancerous tumors that arise in the ileum, the final section of the small intestine. This type of cancer is relatively rare compared to other gastrointestinal malignancies, such as colorectal cancer. The ileum is responsible for nutrient absorption, and tumors in this area can lead to significant complications, including obstruction, perforation, and malabsorption. Symptoms may include abdominal pain, weight loss, changes in bowel habits, and gastrointestinal bleeding. Diagnosis often involves imaging studies such as CT scans or MRIs, endoscopy, and biopsy to confirm malignancy. Due to the rarity of ileal tumors, they can be challenging to diagnose, often being mistaken for other gastrointestinal disorders. Treatment typically involves surgical resection of the tumor, and depending on the stage, may also include chemotherapy or radiation therapy. The prognosis varies based on the tumor's size, location, and metastasis at the time of diagnosis.
Detailed pathology reports, imaging studies, and treatment plans.
Diagnosis and management of ileal tumors, staging, and treatment planning.
Ensure accurate coding of chemotherapy and radiation therapy as adjunct treatments.
Endoscopy reports, biopsy results, and imaging findings.
Evaluation of gastrointestinal symptoms leading to the diagnosis of ileal malignancy.
Documentation must clearly differentiate between benign and malignant findings.
Performed when a malignant tumor is diagnosed in the ileum.
Operative reports detailing the procedure and findings.
Oncologists and surgeons must coordinate documentation for accurate coding.
Common symptoms include abdominal pain, weight loss, changes in bowel habits, and gastrointestinal bleeding. Patients may also experience nausea and vomiting, especially if there is an obstruction.
Diagnosis typically involves imaging studies such as CT scans or MRIs, endoscopic evaluations, and biopsy to confirm malignancy. Pathological examination of tissue samples is crucial for accurate diagnosis.
